RxDoctor Payments Data

Brendan Kelly, DO

Hospitalist · Atlantic City, NJNPI 1629222781

Payments from drug & device makers

$871in general payments, 2019–2025

Across 52 payments — averaging $16.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$175
  • Johnson & Johnson$143
  • Pfizer$132
  • Neurocrine Biosciences, Inc.$115
  • Merck$56
  • Novartis$45
  • plus $205 from 8 others

What the payments were for

  • Food & beverage$871100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$871 in reported general payments places this provider in the 85th percentile of 567 hospitalist providers in New Jersey.

See all hospitalist providers in New Jersey

Medicare billing

Part B allowed, 2024
$189,080
Medicare patients
429
Services billed
1,808

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban80$36,817
Midodrine Hcl39$6,875
JanuviaSitagliptin Phosphate22$6,300
BrilintaTicagrelor22$5,205
Fluticasone-SalmeterolFluticasone Propion/Salmeterol17$4,085
OxycontinOxycodone Hcl21$4,008
Incruse ElliptaUmeclidinium Bromide13$3,976
Insulin Lispro Kwikpen U-100Insulin Lispro25$3,361
Lacosamide11$2,620
Atorvastatin Calcium150$2,230
Ezetimibe12$1,723
Ranolazine ErRanolazine12$1,707
Gabapentin89$1,657
Levetiracetam33$1,399
Pantoprazole Sodium106$1,383

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$132$36,81780 claims
MerckJanuvia$56$6,30022 claims
AstraZenecaBrilinta$29$5,20522 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 567 hospitalist providers in New Jersey.

Other hospitalist in Atlantic City

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →